100 results
Page 2 of 5
8-K
EX-99.1
omoyro
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
8-K
EX-99.1
nysaz6mf
30 Oct 23
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
8:15am
424B3
ux6qk6 343r6xh0xffq5
6 Oct 23
Prospectus supplement
1:08pm
424B3
cfbrvdac2hrpn6 ta
6 Oct 23
Prospectus supplement
1:06pm
424B3
4t5ho
6 Oct 23
Prospectus supplement
1:04pm
424B3
eqntcuh xa0de1u4s7
6 Oct 23
Prospectus supplement
12:59pm
8-K
EX-99.1
ml3pi cj4mrr3
3 Oct 23
Company to finalize labeling with FDA Approvable Letter expected within a month
4:07pm
8-K
EX-9.1
tgwlt6ip22ybc dc2kw
24 Aug 23
Regulation FD Disclosure
5:15pm
8-K
EX-99.1
1epnnp7ozvicmlqip2
14 Aug 23
SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update
6:46pm
424B7
6hb2azk0 675
10 Aug 23
Prospectus with selling stockholder info
4:00pm
424B3
1eg 8sctj
23 May 23
Prospectus supplement
5:29pm
424B3
5is1fduc9bysly3 cu
23 May 23
Prospectus supplement
5:24pm
424B3
wkl19
23 May 23
Prospectus supplement
5:20pm
DEF 14A
fdpw f9dgwz
19 May 23
Definitive proxy
12:06pm
8-K
EX-99.1
rt71z
16 May 23
SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update
4:06pm
424B3
vfxb pbkavb9eob
10 May 23
Prospectus supplement
5:19pm
424B3
20us8v4z8x8ji
10 May 23
Prospectus supplement
5:17pm
424B3
wws0yz4
10 May 23
Prospectus supplement
5:15pm